☆ 4.6 Article

Molecular Analysis of Biliary Tract Cancers with the Custom 3′ RACE-Based NGS Panel

DIAGNOSTICS (2023)

Related references

Note: Only part of the references are listed.

Article Gastroenterology & Hepatology

Charting co-mutation patterns associated with actionable drivers in intrahepatic cholangiocarcinoma

Gajanan Kendre et al.

Summary: This study retrospectively analyzed the genomic data of 6,130 patients diagnosed with intrahepatic cholangiocarcinoma (iCCA), and identified seven oncogenic driver genes and their co-mutational patterns. The study also discovered genetic variations and genomic patterns associated with iCCA, which are important for developing effective treatment strategies and predicting mechanisms of resistance.

JOURNAL OF HEPATOLOGY (2023)

Add to Collection

Article Medicine, General & Internal

Futibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma

Lipika Goyal et al.

Summary: In this study, 103 patients with FGFR2-altered intrahepatic cholangiocarcinoma were treated with futibatinib for a median duration of 17.1 months. The results showed that futibatinib treatment could effectively inhibit tumor growth, improve survival, and maintain quality of life for patients.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

Add to Collection

Article Biochemistry & Molecular Biology

KRAS, NRAS, BRAF, HER2 and MSI Status in a Large Consecutive Series of Colorectal Carcinomas

Aleksandr S. Martianov et al.

Summary: This study analyzed the factors influencing the distribution of actionable genetic alterations in colorectal carcinomas. The study found that there were differences in the distribution of certain genetic alterations based on patients' age and gender. BRAF mutation frequency also showed geographic variation. In addition, a small fraction of CRCs had simultaneous alterations in more than one driver gene.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Review Gastroenterology & Hepatology

Targeting BRCA-mutant biliary tract cancer: Current evidence and future perspectives

Xin Yu Li et al.

Summary: Biliary tract cancers (BTCs) are aggressive tumors of the biliary system that are often diagnosed at an advanced stage with a poor prognosis. BRCA1/2 mutations have been reported in BTC patients, and treatment with PARP inhibitors has shown some effectiveness without severe side effects. The frequencies and types of BRCA1/2 mutations in advanced BTCs vary among studies. Differences in the therapeutic effects and response to immunotherapy between germline and somatic BRCA mutations have been observed.

JOURNAL OF DIGESTIVE DISEASES (2023)

Add to Collection

Review Oncology

Cholangiocarcinoma - novel biological insights and therapeutic strategies

Sumera I. Ilyas et al.

Summary: Cholangiocarcinoma still has a poor prognosis and better understanding of the disease biology is needed for early detection and treatment. In the past 5 years, significant advances have been made in the scientific understanding and clinical management of cholangiocarcinoma, including insights into the tumor microenvironment, progress in liquid biopsy approaches, targeted therapies, immunotherapies, and reassessment of liver transplantation.

NATURE REVIEWS CLINICAL ONCOLOGY (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Cost-Efficient Detection of NTRK1/2/3 Gene Fusions: Single-Center Analysis of 8075 Tumor Samples

Aleksandr A. Romanko et al.

Summary: This study successfully detected various NTRK gene fusions by analyzing the expression imbalances in tumor specimens. NTRK fusions were most commonly observed in pediatric sarcomas and had a lower incidence in other types of tumors. The analysis of NTRK1-3 can serve as a cost-efficient diagnostic method.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Rapid and Cost-Efficient Detection of RET Rearrangements in a Large Consecutive Series of Lung Carcinomas

Vladislav I. Tiurin et al.

Summary: RET-kinase-activating gene rearrangements are found in 1-2% of non-small-cell lung carcinomas (NSCLCs), with reliable detection requiring next-generation sequencing (NGS). A new assay based on the comparison of RNA transcripts of different portions of the RET gene was developed, allowing the detection of RET translocations in NSCLCs. The study found a significant occurrence of RET rearrangements in EGFR/KRAS/ALK/ROS1/BRAF/MET-negative carcinomas and a correlation between RET rearrangement and thymidylate synthase expression in female patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Review Oncology

Immunotherapy in Biliary Tract Cancers: Current Standard-of-Care and Emerging Strategies

Justin H. H. Lo et al.

Summary: Biliary tract cancers are challenging to treat and immunotherapy has shown promising results in combination with chemotherapy. Other immunotherapy approaches, such as immune-stimulating agonists and modified T cells, are being studied. Molecularly targeted therapies and novel immunotherapy strategies are also being explored in clinical trials.

CANCERS (2023)

Add to Collection

Article Oncology

Durable Response after Olaparib Treatment for Perihilar Cholangiocarcinoma with Germline BRCA2 Mutation

Bruno Almeida Costa et al.

Summary: Despite advances in surveillance and management, advanced cholangiocarcinoma still has a poor prognosis. Recent studies have identified actionable genomic alterations, such as homologous recombination deficiency (HRD), that can affect treatment response. This case report discusses a patient with BRCA2-mutant CCA who showed a durable response to olaparib, a PARP inhibitor, after intolerable toxicity with gemcitabine/cisplatin. Further clinical trials are needed to confirm the role of PARP inhibition in similar patients.

ONCOLOGY RESEARCH AND TREATMENT (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Preparation of Duplex Sequencing Libraries for Archival Paraffin-Embedded Tissue Samples Using Single-Strand-Specific Nuclease P1

Natalia V. Mitiushkina et al.

Summary: DNA from formalin-fixed paraffin-embedded (FFPE) tissues is prone to chemical degradation, affecting mutation detection accuracy. By replacing DNA polymerase with a single strand-specific nuclease P1, researchers improved the performance of duplex sequencing in FFPE-derived DNA, resulting in more accurate mutation detection.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Oncology

Comprehensive evaluation of the test for 5′-/3′-end mRNA unbalanced expression as a screening tool for ALK and ROS1 fusions in lung cancer

Natalia Mitiushkina et al.

Summary: The study analyzed ALK/ROS1 fusions and 5'-/3'-end unbalanced expression in NSCLC samples. It demonstrated that variant-specific PCR tests can detect common ALK and ROS1 rearrangements, with additional rare ALK fusions identified by PCR or NGS. While unbalanced gene expression can comprehensively analyze ALK, it is more complicated for the detection of ROS1 fusions, suggesting that variant-specific PCR assays are preferable for ROS1 testing.

CANCER MEDICINE (2022)

Add to Collection

Article Multidisciplinary Sciences

Truncated FGFR2 is a clinically actionable oncogene in multiple cancers

Daniel Zingg et al.

Summary: The truncation of exon 18 of Fgfr2 is identified as a potent driver mutation, while FGFR2 full-length amplifications require cooperation with other driver genes. Therefore, tumors with FGFR2 variants involving truncated E18 should be considered for FGFR-targeted therapies.

NATURE (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Pan-cancer efficacy of pralsetinib in patients with RET fusion-positive solid tumors from the phase 1/2 ARROW trial

Vivek Subbiah et al.

Summary: Pralsetinib is a potent and selective inhibitor of RET receptor tyrosine kinase, showing promising efficacy in patients with diverse RET fusion-positive solid tumors. It demonstrates rapid, robust, and durable anti-tumor activity, regardless of tumor type or RET fusion partner.

NATURE MEDICINE (2022)

Add to Collection

Review Medicine, General & Internal

Target Enrichment Approaches for Next-Generation Sequencing Applications in Oncology

Rajesh R. Singh

Summary: Screening for genomic sequence variants is crucial in precision medicine and next-generation sequencing technologies have become the preferred platforms due to their capacity for massively parallel sequencing. Targeted NGS workflow involves enrichment of the regions of interest, improving the accuracy and cost-effectiveness of screening.

DIAGNOSTICS (2022)

Add to Collection

Article Oncology

Trastuzumab upregulates programmed death ligand-1 expression through interaction with NK cells in gastric cancer

Kohei Yamashita et al.

Summary: The study found that trastuzumab can upregulate PD-L1 expression on gastric cancer cells through interaction with NK cells. These results suggest clinical implications in the assessment of the predictive significance of PD-L1 expression for PD-1 inhibitors.

BRITISH JOURNAL OF CANCER (2021)

Add to Collection

Article Cell Biology

The diversity of tumours with microsatellite instability: molecular mechanisms and impact upon microsatellite instability testing and mismatch repair protein immunohistochemistry

Jinru Shia

Summary: Microsatellite instability (MSI) is recognized as a diverse molecular phenotype in human neoplasms, with variations in genotype and phenotype within and across tumor types. Advances in understanding this diversity have been made, but its potential impact on the effective use of current MSI detection tools is significant.

HISTOPATHOLOGY (2021)

Add to Collection

Article Pathology

Simultaneous Identification of Cell of Origin, Translocations, and Hotspot Mutations in Diffuse Large B-Cell Lymphoma Using a Single RNA-Sequencing Assay

Rory Crotty et al.

Summary: The study used a one-step RNA-based method to classify DLBCL and identify mutations, achieving consistent results with traditional testing methods. The FusionPlex assay showed high accuracy in COO classification, translocation detection, and mutation identification.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2021)

Add to Collection

Letter Gastroenterology & Hepatology

Cholangiocarcinoma with STRN-ALK translocation treated with ALK inhibitors

Marine Valery et al.

DIGESTIVE AND LIVER DISEASE (2021)

Add to Collection

Article Pathology

Comparison of RNA-Based Next-Generation for Sequencing Assays for the Detection of NTRK Gene Fusions

Hyeon J. Park et al.

Summary: The study investigated the performance characteristics of three RNA-based next-generation sequencing methods for detecting NTRK gene fusions and found different sensitivities and specificities among the methods. However, all three methods showed high concordance in clinical sensitivity and equivalent high-level performance in specificity for detecting NTRK fusions in clinical samples.

JOURNAL OF MOLECULAR DIAGNOSTICS (2021)

Add to Collection

Article Genetics & Heredity

Detection of gene fusions using targeted next-generation sequencing: a comparative evaluation

Carina Heydt et al.

Summary: Gene fusions are important targets for cancer therapy in lung cancer. RNA-based parallel sequencing methods are potent tools for reliable detection of targetable gene fusions in clinical diagnostics. DNA-based methods also show promise but may result in more false positive results.

BMC MEDICAL GENOMICS (2021)

Add to Collection

Article Gastroenterology & Hepatology

Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study

Milind Javle et al.

Lancet Gastroenterology & Hepatology (2021)

Add to Collection

Article Oncology

FGFR2 Extracellular Domain In-Frame Deletions Are Therapeutically Targetable Genomic Alterations That Function as Oncogenic Drivers in Cholangiocarcinoma

James M. Cleary et al.

Summary: FGFR2 EIDs are shown to be an alternative mechanism of FGFR2 activation in intrahepatic cholangiocarcinoma (IHCC), predicting sensitivity to FGFR inhibitors and treatment benefits in patients with these alterations.

CANCER DISCOVERY (2021)

Add to Collection

Letter Pathology

Identification of an EML4-ALK rearrangement in an intrahepatic cholangiocarcinoma

Loetitia Favre et al.

PATHOLOGY INTERNATIONAL (2021)

Add to Collection

Article Oncology

Targeting extracellular and juxtamembrane FGFR2 mutations in chemotherapy-refractory cholangiocarcinoma

Michael Bitzer et al.

Summary: In this study, two iCCA patients with extracellular and juxtamembrane FGFR2 mutations were treated with an FGFR-inhibiting tyrosine kinase inhibitor under the guidance of MTB, leading to rapid and prolonged partial response. This suggests the importance of predicting the functional consequences of FGFR2 mutations for guiding treatment decisions in iCCA patients.

NPJ PRECISION ONCOLOGY (2021)

Add to Collection

Article Oncology

Targetable molecular alterations in congenital glioblastoma

Ahmed Gilani et al.

JOURNAL OF NEURO-ONCOLOGY (2020)

Add to Collection

Article Oncology

Intergenic Breakpoints Identified by DNA Sequencing Confound Targetable Kinase Fusion Detection in NSCLC

Weihua Li et al.

JOURNAL OF THORACIC ONCOLOGY (2020)

Add to Collection

Article Oncology

Ivosidenib in IDH1-mutant, chemotherapy-refractory Croatia& cholangiocarcinoma (ClarlDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study

Ghassan K. Abou-Alfa et al.

LANCET ONCOLOGY (2020)

Add to Collection

Article Oncology

Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study

Ghassan K. Abou-Alfa et al.

LANCET ONCOLOGY (2020)

Add to Collection

Article Oncology

Novel Gene Fusions in Glioblastoma Tumor Tissue and Matched Patient Plasma

Lan Wang et al.

CANCERS (2020)

Add to Collection

Review Oncology

Narrative review of molecular pathways of kinase fusions and diagnostic approaches for their detection in non-small cell lung carcinomas

Matthias S. Matter et al.

TRANSLATIONAL LUNG CANCER RESEARCH (2020)

Add to Collection

Article Oncology

Lack of Targetable FGFR2 Fusions in Endemic Fluke-Associated Cholangiocarcinoma

Sarinya Kongpetch et al.

JCO GLOBAL ONCOLOGY (2020)

Add to Collection

Article Oncology

Response to Crizotinib in ROS1 Fusion-Positive Intrahepatic Cholangiocarcinoma

Christopher D. Jakubowski et al.

JCO PRECISION ONCOLOGY (2020)

Add to Collection

Review Oncology

Targeting BRAF-Mutant Biliary Tract Cancer: Recent Advances and Future Challenges

Alessandro Rizzo et al.

CANCER CONTROL (2020)

Add to Collection

Article Oncology

High Yield of RNA Sequencing for Targetable Kinase Fusions in Lung Adenocarcinomas with No Mitogenic Driver Alteration Detected by DNA Sequencing and Low Tumor Mutation Burden

Ryma Benayed et al.

CLINICAL CANCER RESEARCH (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Comparative analysis of expression of mutant and wild-type alleles is essential for reliable PCR-based detection of MET exon 14 skipping

Natalia Mitiushkina et al.

BIOCHIMIE (2019)

Add to Collection

Article Biotechnology & Applied Microbiology

Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods

Brian J. Haas et al.

GENOME BIOLOGY (2019)

Add to Collection

Review Oncology

Frequency and prognostic significance of isocitrate dehydrogenase 1 mutations in cholangiocarcinoma: a systematic literature review

Audra N. Boscoe et al.

JOURNAL OF GASTROINTESTINAL ONCOLOGY (2019)

Add to Collection

Article Oncology

Trastuzumab upregulates PD-L1 as a potential mechanism of trastuzumab resistance through engagement of immune effector cells and stimulation of IFN gamma secretion

Bharat K. R. Chaganty et al.

CANCER LETTERS (2018)

Add to Collection

Article Oncology

Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention

Maeve A. Lowery et al.

CLINICAL CANCER RESEARCH (2018)

Add to Collection

Review Oncology

HER2/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target?

Salvatore Galdy et al.

CANCER AND METASTASIS REVIEWS (2017)

Add to Collection

Article Biochemistry & Molecular Biology

UMI-tools: modeling sequencing errors in Unique Molecular Identifiers to improve quantification accuracy

Tom Smith et al.

GENOME RESEARCH (2017)

Add to Collection

Article Cell Biology

Role of Next-Generation Sequencing as a Diagnostic Tool for the Evaluation of Bone and Soft-Tissue Tumors

Kinga Szurian et al.

PATHOBIOLOGY (2017)

Add to Collection

Article Oncology

Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma

Apinya Jusakul et al.

CANCER DISCOVERY (2017)

Add to Collection

Article Oncology

Rare Incidence of ROS1 Rearrangement in Cholangiocarcinoma

Sun Min Lim et al.

CANCER RESEARCH AND TREATMENT (2017)

Add to Collection

Article Oncology

The FGFR Landscape in Cancer: Analysis of 4,853 Tumors by Next-Generation Sequencing

Teresa Helsten et al.

CLINICAL CANCER RESEARCH (2016)

Add to Collection

Review Oncology

Genomic Profiling of Biliary Tract Cancers and Implications for Clinical Practice

Apurva Jain et al.

CURRENT TREATMENT OPTIONS IN ONCOLOGY (2016)

Add to Collection

Article Gastroenterology & Hepatology

Fibroblast Growth Factor Receptor 2 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Cholangiocarcinoma

Yasuhito Arai et al.

HEPATOLOGY (2014)

Add to Collection

Article Pathology

Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma

Rondell P. Graham et al.

HUMAN PATHOLOGY (2014)

Add to Collection

Article Pathology

BRAF V600E-specific immunohistochemistry reveals low mutation rates in biliary tract cancer and restriction to intrahepatic cholangiocarcinoma

Benjamin Goeppert et al.

MODERN PATHOLOGY (2014)

Add to Collection

Article Biochemistry & Molecular Biology

Anchored multiplex FOR for targeted next-generation sequencing

Zongli Zheng et al.

NATURE MEDICINE (2014)

Add to Collection

Article Biochemical Research Methods

STAR: ultrafast universal RNA-seq aligner

Alexander Dobin et al.

BIOINFORMATICS (2013)

Add to Collection

Review Genetics & Heredity

Human housekeeping genes, revisited

Eli Eisenberg et al.

TRENDS IN GENETICS (2013)

Add to Collection

Review Radiology, Nuclear Medicine & Medical Imaging

Liver Flukes: the Malady Neglected

Jae Hoon Lim

KOREAN JOURNAL OF RADIOLOGY (2011)

Add to Collection

Article Biochemical Research Methods

A guide for in-house design of template-switch-based 5′ rapid amplification of cDNA ends systems

Fernando Lopes Pinto et al.

ANALYTICAL BIOCHEMISTRY (2010)

Add to Collection

Article Biochemistry & Molecular Biology

ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data

Kai Wang et al.

NUCLEIC ACIDS RESEARCH (2010)

Add to Collection

Article Genetics & Heredity

3′ rapid amplification of cDNA ends (RACE) walking for rapid structural analysis of large transcripts

T Ozawa et al.

JOURNAL OF HUMAN GENETICS (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.